DNAJC19 Antikörper (C-Term)
Kurzübersicht für DNAJC19 Antikörper (C-Term) (ABIN929358)
Target
Alle DNAJC19 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Purified
-
Immunogen
- DNAJC19 antibody was raised in rabbit using the C terminal of DNAJC19 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
DNAJC19 Blocking Peptide, catalog no. 33R-5000, is also available for use as a blocking control in assays to test for specificity of this DNAJC19 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- DNAJC19 (DnaJ (Hsp40) Homolog, Subfamily C, Member 19 (DNAJC19))
-
Andere Bezeichnung
- DNAJC19
-
Hintergrund
- The protein encoded by this gene is thought to be part of a complex involved in the ATP-dependent transport of transit peptide-containing proteins from the inner cell membrane to the mitochondrial matrix. Defects in this gene are a cause of 3-methylglutaconic aciduria type 5 (MGA5), also known as dilated cardiomyopathy with ataxia (DCMA). Several transcript variants, some protein-coding and some not, have been found for this gene. Synonyms: Polyclonal DNAJC19 antibody, Anti-DNAJC19 antibody, DnaJ, Hsp40 homolog, subfamily C, member 19 antibody, TIM14 antibody, TIMM14 antibody.
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-